Dimenhydrinate
Aminoalkyl Ethers
Sold as Motion Sickness · DRAMAMINE · Dramamine for Kids · ANTI-NAUSEANT · Motion Sickness Relief
- Drug class
- Aminoalkyl Ethers
- Availability
- Over-the-counter
- Routes
- Intravenous, Intramuscular, Rectal, Oral
- Markets covered
- 3
- Products on record
- 32
- FDA reports (12 mo)
- 639
Overview
Dimenhydrinate is an active pharmaceutical ingredient in the Aminoalkyl Ethers group (R06AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 26 | December 5, 2025 |
| US United States | FDA | 3 | May 7, 2026 |
| GB United Kingdom | MHRA | 3 | October 3, 2025 |
CACanada· Health Canada
26 products
Uses
AND CLINICAL USE ................................................................................................... 4 CONTRAINDICATIONS .........................................................................................................................
4 WARNINGS AND PRECAUTIONS ....................................................................................................... 4 ADVERSE REACTIONS .........................................................................................................................
7 DRUG INTERACTIONS ......................................................................................................................... 8 DOSAGE AND ADMINISTRATION .....................................................................................................
8 ACTION AND CLINICAL PHARMACOLOGY .................................................................................. 10 DOSAGE FORMS, COMPOSITION AND PACKAGING ................................................................... 11 STORAGE AND STABILITY ...............................................................................................................
USUnited States· FDA
3 products
Uses
Uses for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
How to take
GBUnited Kingdom· MHRA
3 products
Uses
Treatment of vertigo symptoms of various origins. Arlevert is indicated in adults.
How to take
Drug interactions
Known interactions involving Dimenhydrinate. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 258. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 00013609 · revised March 22, 2025
- [2]FDA DailyMed · 00a327c6-6b86-47… · revised May 7, 2026 [PDF]
- [3]MHRA (UK) · PL112490001 · revised June 20, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.